PENTAX Medical welcomes its new General Manager Marketing EMEA
Hamburg, Germany, December 2nd 2020 – PENTAX Medical, a division of the HOYA Group, announced today the appointment of Mr. Michael Unger as General Manager Marketing, Product and Business Development EMEA, effective December 1st 2020. He will take over the role from Mrs. Mariuccia Zambelli, who worked for the organization since 2005.
Michael Unger has many years of international sales and marketing experience in the healthcare sector. Before joining PENTAX Medical he was a General Manager for a leading global manufacturer of high-end monitor solutions. “Having been a part of PENTAX Medical for almost 2 years, it has been exhilarating to grow and develop the business. I’m excited to take over this role from my predecessor Mrs Zambelli who did a great job over the last 15 years. I’m looking forward to further build on PENTAX Medical’s position as the preferred partner of choice in flexible endoscopy for the complete clinical pathway including therapeutics. In addition, my target is to continue driving the company’s strategic objectives under the Triple Aim and support sustainable growth across the region.” said Michael Unger.
Rainer Burkard, President EMEA PENTAX Medical: “We like to thank Mariuccia for her 15 years of dedication and support to PENTAX Medical and wish her all the best for her future and we like to welcome Mr. Michael Unger in his new role. Michael has been pivotal to further develop our offer in the Therapeutics arena in his position as General Manager Business Development in Therapeutics & ENT since he has started April 2019. We are very pleased that he accepted this promotion as General Manager Marketing, Product and Business Development EMEA and looking forward to working with him within his extended responsibility. PENTAX Medical’s expansion in the Therapeutics area is an important strategic milestone for us and we are certain this will further flourish under the leadership of Michael.”
About PENTAX Medical
PENTAX Medical is a division of HOYA Group. The company’s mission is to improve the standard of patient care and quality of healthcare delivery by providing the best endoscopic products and services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY.
Through providing endoscopic imaging devices and solutions to the global medical community and with its headquartered in Japan, PENTAX Medical has a worldwide focus and a strong presence with R&D, regional sales, service, and in-country facilities in multiple regions around the globe.
PENTAX Medical’s Triple Aim program strives to deliver on the commitment to support its customers and their healthcare organization’s wider objectives through a transparent partnership and by providing the highest quality solutions to help them reach their goals. Enabling customers to improve patient outcomes by offering evidenced based solutions across the continuum of care, dedicated to their needs. From screening through to therapy with full scalabilities. Ensuring values by supporting the customers to improve their efficiency and minimize their healthcare costs. Enriching patient and provider’s experience by empowering every member of the care team to achieve optimal outcomes through products, education and support. For more information, please visit: www.pentaxmedical.com.
Founded in 1941 in Tokyo, Japan, HOYA Corporation is a global technology and med-tech company and a leading supplier of innovative high-tech and medical devices. HOYA is active in the fields of healthcare and information technology, providing eyeglasses, medical endoscopes, intraocular lenses, optical lenses, as well as key components for semiconductor devices, LCD panels, and hard disk drives. With over 150 offices and subsidiaries worldwide, HOYA currently employs a multinational workforce of 37,000 people. For more information, please visit http://www.hoya.com.